eliquis apixaban eliquis apixaban eliquis apixaban logo

This information is intended for healthcare professionals based in the UK.

If you are not a healthcare professional in the UK, please click here.

For Prescribing and Adverse Event reporting information, click here.

mob-img
Home > HCP > Resources > Patient Materials > Patient Information Booklets - VTE Prophylaxis

PATIENT INFORMATION BOOKLET FOR ADULT PATIENTS ON APIXABAN FOR PREVENTION OF VTE AFTER ELECTIVE HIP OR KNEE REPLACEMENT SURGERY

booklet for adult patients with nvaf on eliquis (apixaban) for stroke prevention

This booklet is intended only for patients prescribed ELIQUIS (apixaban) for the indication shown, and should only be read after patients have been prescribed ELIQUIS. This booklet is not intended to replace the Patient Information Leaflet.

This booklet may be read in its electronic form (PDF) or it may be printed and read.

If a Patient Information Booklet is printed, please ensure that:

  • It is printed in its entirety. Please do not attempt to print and use individual pages in isolation, as it has been designed to be printed in its entirety
  • Its content is not edited or altered in any way.
  • It is printed in colour.
  • It is printed in A4 size.
  • The pages are placed in the correct order as per the page numbering.

Please download the Patient Information Booklet below:

ENGLISH ?

This booklet is also available to patients prescribed
ELIQUIS via the patient section of the website.
Purple information icon ELIQUIS (apixaban) SmPC

Please click here to access the ELIQUIS SmPC.

Purple information icon ELIQUIS (apixaban) Patient Information Leaflet

Please click here to access the ELIQUIS Patient Information Leaflet.

VTE= Venous thromboembolic events

Reference

  1. ELIQUIS® (apixaban) Summary of Product Characteristics.

You may contact our EU Data Protection Officer at EUDPO@BMS.com to exercise any data privacy rights that you may have, as well as to raise any concerns or questions in relation to the handling of your personal data by Bristol-Myers Squibb Company.

bristol myers squibb logo

© 2020 Bristol-Myers Squibb Pharmaceuticals Limited

All corporate names and logos of BMS and/or of its products are trademarks of Bristol-Myers Squibb Company and are protected by national and international intellectual and industrial property laws. All rights reserved over the content of this website.

Your use of this website is subject to the Legal Notice, the Privacy and Cookie Policy, the Pharmacovigilance Notice and the applicable laws and regulations.

Date of prep is December 2020
432UK2000589-01